We are live on ! Find out more
AQST icon

Aquestive Therapeutics
AQST

116 hedge funds and large institutions have $158M invested in Aquestive Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 53 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more repeat investments, than reductions

Existing positions increased: 53 | Existing positions reduced: 26

21% more capital invested

Capital invested by funds: $131M → $158M (+$26.9M)

3.19% more ownership

Funds ownership: 44.76% → 47.95% (+3.2%)

4% less funds holding

Funds holding: 121 → 116 (-5)

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less call options, than puts

Call options by funds: $729K | Put options by funds: $1.17M

Holders
116
Holders Change
-5
Holders Change %
-4.13%
% of All Funds
1.53%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
15
Increased
53
Reduced
26
Closed
19
Calls
$729K
Puts
$1.17M
Net Calls
-$440K
Net Calls Change
+$92K

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$7.81M
2
SCM
Sio Capital Management
New York
+$1.59M
3
BlackRock
BlackRock
New York
+$1.55M
4
EAM
Everstar Asset Management
North Carolina
+$1.03M
5
PFCS
Pale Fire Capital SE
Czech Republic
+$977K

Top Sellers

Rank Fund Capital Flow
1
PA
Perceptive Advisors
New York
-$4.41M
2
SCM
Stonepine Capital Management
Oregon
-$3.04M
3
Citadel Advisors
Citadel Advisors
Florida
-$882K
4
Goldman Sachs
Goldman Sachs
New York
-$844K
5
ECM
ExodusPoint Capital Management
New York
-$549K
Name Holding Trade Value Shares
Change 		Change in
Stake
Financial Engines Advisors
26
Financial Engines Advisors
California
$903K +$782K +272,686 New
Wellington Management Group
27
Wellington Management Group
Massachusetts
$812K +$114K +39,755 +19%
Charles Schwab
28
Charles Schwab
California
$809K +$96.7K +33,697 +16%
LI
29
Latash Investments
Alaska
$805K – – –
Two Sigma Investments
30
Two Sigma Investments
New York
$794K -$379K -132,149 -36%
Walleye Capital
31
Walleye Capital
New York
$787K +$569K +198,323 +501%
N
32
Nuveen
North Carolina
$667K -$101K -35,056 -15%
GCP
33
GSA Capital Partners
United Kingdom
$618K +$536K +186,692 New
Bank of New York Mellon
34
Bank of New York Mellon
New York
$612K +$46K +16,028 +9%
Osaic Holdings
35
Osaic Holdings
Arizona
$581K -$2.06K -717 -0.4%
DC
36
Diametric Capital
Massachusetts
$547K +$474K +165,373 New
Barclays
37
Barclays
United Kingdom
$509K +$203K +70,871 +85%
Citadel Advisors
38
Citadel Advisors
Florida
$504K -$882K -307,394 -67%
EC
39
EntryPoint Capital
New York
$494K -$125K -43,600 -23%
DCM
40
DAFNA Capital Management
California
$470K – – –
RhumbLine Advisers
41
RhumbLine Advisers
Massachusetts
$466K +$105K +36,509 +35%
Russell Investments Group
42
Russell Investments Group
United Kingdom
$423K +$6.33K +2,207 +2%
BCM
43
Bridgeway Capital Management
Texas
$390K -$143K -50,000 -30%
Wells Fargo
44
Wells Fargo
California
$342K +$138K +47,979 +87%
HighTower Advisors
45
HighTower Advisors
Illinois
$330K -$26K -9,050 -8%
Creative Planning
46
Creative Planning
Kansas
$327K +$37.7K +13,130 +15%
AllianceBernstein
47
AllianceBernstein
Tennessee
$292K +$134K +46,800 +113%
PCM
48
Penn Capital Management
Pennsylvania
$288K +$1.43K +497 +0.6%
LPL Financial
49
LPL Financial
California
$258K +$223K +77,888 New
Marshall Wace
50
Marshall Wace
United Kingdom
$240K +$208K +72,579 New
1
2
3 4 5

AQST Hedge Fund Activity: Q2 2025 in Review

116 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Aquestive Therapeutics (AQST) for Q2 2025, worth a combined $158M — up 21% from $131M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of AQST and 15 opened new positions — a net loss of 4 holders — while 26 trimmed existing stakes and 53 added.

The largest buyer was Millennium Management, adding an estimated $7.81M. The largest seller was Perceptive Advisors, cutting an estimated $4.41M.

  • 116 institutional investors held Aquestive Therapeutics (AQST) as of Q2 2025, down from 121 in Q1 2025.
  • Funds reported $158M of Aquestive Therapeutics stock for Q2 2025, up 21% quarter-over-quarter.
  • 15 funds opened new Aquestive Therapeutics positions in Q2 2025 and 19 closed out, a net change of -4 holders.
  • The largest Aquestive Therapeutics buyer in Q2 2025 was Millennium Management, an estimated $7.81M added.
  • The largest Aquestive Therapeutics seller in Q2 2025 was Perceptive Advisors, an estimated $4.41M sold.

Based on aggregated 13F filings for Q2 2025.